Clinical Trials
7 trialsNCT00530218 2017-12-02
Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
City of Hope Medical Center
Phase 2 Completed
NCT00006264 2016-02-03
Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System Lymphoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT02202564 2014-07-29
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Huazhong University of Science and Technology
Phase 2 Completed
NCT00005025 2013-11-06
Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00217503 2013-06-20
Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00917826 2011-08-01
Study of Arginine Butyrate and Ganciclovir/Valganciclovir in EBV(+) Lymphoid Malignancies
HemaQuest Pharmaceuticals Inc.
Phase 2 Terminated
NCT00992732 2011-08-01
Study of HQK-1004 and Valganciclovir to Treat Epstein-Barr Virus (EBV) - Positive Lymphoid Malignancies or Lymphoproliferative Disorders
HemaQuest Pharmaceuticals Inc.
Phase 2 Terminated